NATTOPHARMA ASA More news
| Managers | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 52 | 15-12-31 |
Robert Schrama
DFI | Director of Finance/CFO | - | 20-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Annette Elmqvist
BRD | Director/Board Member | 75 | - |
Frode Marc Bohan
FOU | Founder | 56 | 04-11-03 |
| Director/Board Member | 50 | 11-01-31 |
Nattopharma ASA is a Norway-based biotechnology company, which sells and develops products containing natural vitamin K2. The Company markets its products under its own trademark MenaQ7, principally in Europe and North America. MenaQ7 is provided either as powder or as an oil solution, and is used in stand-alone form, in complex dietary products and as additives to functional products. Nattopharma ASA offers contract manufacturing of dietary products, biochemical tests, marketing and sales support services. It provides its products primarily to the healthcare, supplement and functional food markets. The Company has an alliance with VitaK BV, at the Cardiovascular Research Institute (CARIM) at the University of Maastricht in the Netherlands.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +28.79% | 676B | |
| +25.24% | 554B | |
| -7.64% | 349B | |
| +15.00% | 318B | |
| +5.99% | 291B | |
| +3.25% | 210B | |
| -0.29% | 204B | |
| -9.82% | 194B | |
| -11.71% | 144B |
